Rinsho Shinkeigaku (Clinical Neurology)

  • HOME
  • Rinsho Shinkeigaku (Clinical Neurology)
  • Vol.49 No.11

Vol.49 No.11 contents

The 50th Annual Meeting of the Japanese Society of Neurology

What I have learned and accomplished through research on multiple sclerosis (MS)

Yasuto Itoyama, M.D.

CLINICA NEUROL, 49: 699|707, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

RESCUE TREATMENTS FOR MULTIPLE SCLEROSIS

Brian G. Weinshenker, M.D., FRCP (C)

CLINICA NEUROL, 49: 708|714, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Clinical and Pathological Topics of Multiple Sclerosis

Hans Lassmann, M.D.

CLINICA NEUROL, 49: 715|718, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Fine structure of neuronal and glial processes in neuropathology, a personal historical note

Asao Hirano, M.D.

CLINICA NEUROL, 49: 719|723, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

The Japanese Society of Neurology. In commemoration of the 50th anniversary of the founding

Akira Takahashi, M.D.

CLINICA NEUROL, 49: 724|730, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Independent action of The Japanese Society of Neurology is a driving force behind the development of Japanese Neurology

Shukuro Araki, M.D.

CLINICA NEUROL, 49: 731|736, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Development of Japanese Neurology in the last half century: A global perspective

Jun Kimura, M.D.

CLINICA NEUROL, 49: 737|740, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Development of neurology in Japan and its contribution to elucidate and resolve the sociomedical problems

Shigeki Kuzuhara, M.D.

CLINICA NEUROL, 49: 741|744, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

How ought to be the specialists of neurology certified by Japanese Society of Neurology

Norihiro Suzuki, M.D.

CLINICA NEUROL, 49: 745|746, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Molecular-targeted therapy for neurodegenerative diseases

Gen Sobue, M.D.

CLINICA NEUROL, 49: 747|749, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Molecular mechanism for spinocerebellar ataxias

Osamu Onodera, M.D., Ph.D.

CLINICA NEUROL, 49: 750|752, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

The studies of gene therapy for Parkinson's disease

Hideki Mochizuki, M.D.

CLINICA NEUROL, 49: 753|755, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Approach of gene medical treatment in neurological diseases with the neurologist's "Approach of support to the patients with inherited and incurable neurological diseases."

Takanori Hazama1), Jin-ichi Sawada1) and Tatsushi Toda2)

CLINICA NEUROL, 49: 756|761, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 762|764, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 765|768, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

New international classification of epilepsy and new antiepileptic drugs for medically intractable epilepsy

Sadatoshi Tsuji, M.D.

CLINICA NEUROL, 49: 769|773, 2009

Unique clinical features and pathophysiology of anti-NMDA receptor encephalitis

Takahiro Iizuka, M.D.

CLINICA NEUROL, 49: 774|778, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

The mechanism and control of neuropathic pain

Kazuhide Inoue, Ph.D.

CLINICA NEUROL, 49: 779|782, 2009

The TDP-43 proteinopathies, toward understanding of the molecular pathogenesis

Masato Hasegawa, M.D.1), Takashi Nonaka, M.D.1), Makiko Yamashita, M.D.1), Fuyuki Kametani, M.D.1), Tetsuaki Arai, M.D.2), Mari Yoshida, M.D.3), Yoshio Hashizume, M.D.3), Kuniaki Tsuchiya, M.D.4) and Haruhiko Akiyama, M.D.2)

CLINICA NEUROL, 49: 783|785, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Regulation, structure and function of brain aquaporin

Masato Yasui, M.D., Ph.D.

CLINICA NEUROL, 49: 786|788, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Recent advance in research for myasthenia gravis, in relation to various antibodies affecting synaptic structure and function

Masaharu Takamori, M.D.

CLINICA NEUROL, 49: 789|793, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Conscious awareness of cognitive processes and their dysfunction

Kyoko Suzuki, M.D.

CLINICA NEUROL, 49: 794|796, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 797|797, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Mechanism underlying thrombus formation in cerebral infarction

Kazuo Kitagawa, M.D. and Saburo Sakoda, M.D.

CLINICA NEUROL, 49: 798|800, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Intravenous rt-PA therapy for acute ischemic stroke: efficacy and limitations

Kazunori Toyoda, M.D.

CLINICA NEUROL, 49: 801|803, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Transcranial sonothrombolysis

Hiroshi Furuhata

CLINICA NEUROL, 49: 804|806, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 807|809, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 810|810, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Exploration of pathogenesis and therapy development for ALS employing sporadic disease model

Fumiaki Tanaka, M.D.1), Masahiro Waza, M.D.1), Masahiko Yamamoto, M.D.2) and Gen Sobue, M.D.1)

CLINICA NEUROL, 49: 811|813, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor

Masashi Aoki, M.D., Ph.D., Hitoshi Warita, M.D., Ph.D., Naoki Suzuki, M.D., Ph.D. and Yasuto Itoyama, M.D., Ph.D.

CLINICA NEUROL, 49: 814|817, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Future perspectives of immunotherapy against ALS

Makoto Urushitani

CLINICA NEUROL, 49: 818|820, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Gene therapy of ALS with RNA interference

Takanori Yokota, M.D.

CLINICA NEUROL, 49: 821|823, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 824|824, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Regeneration of the central nervous system using iPS cell-technologies

Hideyuki Okano, M.D.

CLINICA NEUROL, 49: 825|826, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

The preservative therapies of injured central nervous system by gene transfer

Hiroshi Kiyama, PhD

CLINICA NEUROL, 49: 827|829, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Endogenous repair mechanisms in the brain

Kazunobu Sawamoto

CLINICA NEUROL, 49: 830|833, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Future of stem cell therapy for neuronal regeneration

Jun Takahashi, M.D.

CLINICA NEUROL, 49: 834|836, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 837|837, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Pre-symptomatic detection of Alzheimer's disease and mild cognitive impairment

Hiroyuki Arai, M.D.

CLINICA NEUROL, 49: 838|840, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Early diagnostic biomarker for Alzheimer's disease in now and future

Katsuya Urakami, M.D. and Miyoko Taniguchi, Ph.D.

CLINICA NEUROL, 49: 841|844, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Alzheimer's disease treatment by inhibition/modulation of the γ-secretase activity

Taisuke Tomita, M.D.

CLINICA NEUROL, 49: 845|847, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Vaccination therapy for Alzheimer's disease

Takeshi Tabira

CLINICA NEUROL, 49: 848|850, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 851|851, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Development of therapy for distal myopathy with rimmed vacuoles

Ichizo Nishino, M.D., Ph.D., May Christine V. Malicdan, M.D. and Satoru Noguchi, Ph.D.

CLINICA NEUROL, 49: 852|855, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Exon skipping therapy for Duchenne muscular dystrophy by using antisense Morpholino

Shin'ichi Takeda, M.D., Ph.D.

CLINICA NEUROL, 49: 856|858, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Pathomechanism and therapeutic strategy of Fukuyama congenital muscular dystrophy and related disorders

Tatsushi Toda, M.D.

CLINICA NEUROL, 49: 859|862, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Establishment of an evaluation method for muscular dystrophy and a patient registration system for clinical trials

Mitsuru Kawai, M.D.

CLINICA NEUROL, 49: 863|866, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 867|867, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 868|869, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Delivery of medical care to the neurological intractable diseases at home

Mieko Ogino, M.D., Ph.D. MMA.

CLINICA NEUROL, 49: 870|871, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Disaster medical network for the patients with intractable disease-experiences of two large earthquakes

Takashi Nakajima, M.D., Ph.D.

CLINICA NEUROL, 49: 872|876, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

The study and development of a new automatic suction system (SS) of intratracheal sputa -We aim at the improvement of QOL of many patients with tracheostomy mechanical ventilation (TMV) and these family's member by this new autonomic SS-

Youichi Hokezu, M.D.1), Makoto Yamamoto, M.D2), Syuichi Tokunaga3), Makoto Niikura4), Keiji Nagamatsu, M.D5), Jun-ichi Kira, M.D6), Toshihide Fukunaga, M.D7), Kouji Shima, M.D8), Seiji Kikuchi, M.D8), Itaru Kimura, M.D9), Kiyohiko Kondo, M.D10), Teruhiko Mori, M.D11), Katumasa Goto, M.D11), Shigeru Takigami, M.D12), Keiichi Shioya, M.D13) and Minako Uehara, M.N14)

CLINICA NEUROL, 49: 877|880, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 881|881, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 882|884, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Pathogenesis of sporadic Parkinson's disease: Contribution of genetic and environmental risk factors

Ryosuke Takahashi, M.D., Jun Kawamata, M.D. and Hiroki Takeuchi, M.D.

CLINICA NEUROL, 49: 885|887, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Pathophysiological process underlying Parkinson's disease: Motor & Non-motor symptoms

Atsushi Takeda, M.D.1), Toru Baba, M.D.1), Akio Kikuchi, M.D.1), Naoto Sugeno, M.D.1), Takafumi Hasegawa, M.D.1), Yasuto Itoyama, M.D.1), Toshiyuki Ishioka, M.D.2), Kazumi Hirayama, M.D.2) and Etsuro Mori, M.D.2)

CLINICA NEUROL, 49: 888|889, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Cell therapy for Parkinson disease

Shin-ichi Muramatsu, M.D.

CLINICA NEUROL, 49: 890|892, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 893|893, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Clinical Overview of Neuromyelitis Optica

Brian G. Weinshenker, M.D., FRCP (C)

CLINICA NEUROL, 49: 894|895, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Pathology of neuromyelitis optica

Tatsuro Misu, M.D.

CLINICA NEUROL, 49: 896|899, 2009

Experimental Models of Neuromyelitis Optica

Hans Lassmann, M.D.

CLINICA NEUROL, 49: 900|901, 2009

Treatment of NMO

Takahiko Saida, M.D., Ph.D.

CLINICA NEUROL, 49: 902|905, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 906|906, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Molecular genetic approach to spinocerebellar ataxias

Kinya Ishikawa, Taro Ishiguro, Makoto Takahashi, Nozomu Sato, Takeshi Amino, Yusuke Niimi and Hidehiro Mizusawa

CLINICA NEUROL, 49: 907|909, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Genetic approach for understanding of the late-onset mechanisms of polyglutamine disease

Erina Kuranaga1)2), Ayako Tonoki1)2) and Masayuki Miura1)2)

CLINICA NEUROL, 49: 910|912, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases

Yoshitaka Nagai, M.D., Ph.D.

CLINICA NEUROL, 49: 913|916, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Molecular-targeted therapies for spinal and bulbar muscular atrophy

Masahisa Katsuno, M.D.1)2), Haruhiko Banno, M.D.1), Keisuke Suzuki, M.D.1), Hiroaki Adachi, M.D.1), Fumiaki Tanaka, M.D.1) and Gen Sobue, M.D.1)

CLINICA NEUROL, 49: 917|920, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 921|921, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Molecular PET imaging for in vivo detection of amyloid in the human brain

Nobuyuki Okamura

CLINICA NEUROL, 49: 922|924, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Imaging of brain microgliosis by PET

Yasuomi Ouchi, M.D.

CLINICA NEUROL, 49: 925|928, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

In-vivo imaging for pursuing molecular cascades in the pathogenesis of neurodegenerative diseases

Makoto Higuchi, M.D.

CLINICA NEUROL, 49: 929|932, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Neuroimaging studies on higher brain functions

Toshikatsu Fujii, M.D.

CLINICA NEUROL, 49: 933|934, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 935|935, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

A history for 50 years of the prion disease research

Tetsuyuki Kitamoto

CLINICA NEUROL, 49: 936|938, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Prion disease surveillance in Japan: analysis of 1,241 patients

Masahito Yamada, M.D.1)6), Ichiro Nozaki, M.D.1), Tsuyoshi Hamaguchi, M.D.1), Moeko Noguchi-Shinohara, M.D.1), Tetsuyuki Kitamoto, M.D.2)6), Yosikazu Nakamura, M.D.3)6), Takeshi Sato, M.D.4)6) and Hidehiro Mizusawa, M.D.5)6)

CLINICA NEUROL, 49: 939|942, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 943|945, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Innovation of therapeutics and prophylaxis for prion diseases

Katsumi Doh-ura, M.D.

CLINICA NEUROL, 49: 946|948, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 949|949, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

A wide spectrum of Hereditary Motor Sensory Neuropathy (HMSN)

Masanori Nakagawa, M.D.

CLINICA NEUROL, 49: 950|952, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Therapeutic strategy for familial amyloid polyneuropathy (FAP)

Shu-ichi Ikeda, M.D.

CLINICA NEUROL, 49: 953|955, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Immune-mediated neuropathies

Susumu Kusunoki

CLINICA NEUROL, 49: 956|958, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Peripheral neuropathy and blood-nerve barrier

Takashi Kanda, M.D.

CLINICA NEUROL, 49: 959|962, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

CLINICA NEUROL, 49: 963|963, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Neurology Education and the History of the Korean Neurological Association

Kwang-Woo Lee, M.D.

CLINICA NEUROL, 49: 964|965, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

Neurology Education and History of Taiwan Neurological Society

Ching-Piao Tsai, Msc, M.D.

CLINICA NEUROL, 49: 966|967, 2009

The 50th Annual Meeting of the Japanese Society of Neurology

History of neurology and education of neurology in Japan

Shigeki Kuzuhara, M.D.

CLINICA NEUROL, 49: 968|971, 2009